Veracyte | VCYT - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Agenus USD 323.49M 36.36M 2025-12
Agilent USD 2.23B 113M 2025-12
Anika Therapeutics USD 21.91M 2.82M 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Exact Sciences USD 641.15M 56.89M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Illumina USD 1.59B 377M 2025-12
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Laboratory Of America USD 2.82B 194.3M 2025-12
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
Myriad Genetics USD 133.8M 14.2M 2025-12
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Siemens EUR 49.35B 2.09B 2025-12
Sonic Healthcare AUD 2.23B 92.84M 2024-12
Thermo Fisher Scientific USD 15.19B 301M 2025-12
Veracyte USD 59.94M 12.22M 2025-12
Waters USD 1.24B 11.8M 2025-12